<DOC>
	<DOCNO>NCT02524262</DOCNO>
	<brief_summary>Atrophic gastritis hypochlorhydric milieu risk factor gastric cancer . Microbes colonize acid-free stomach oxidize ethanol acetaldehyde , group 1 carcinogen . The aim ass gastric production acetaldehyde inert condensation product , non-toxic 4-methyltiazolidine-2-carboxylic acid ( MTCA ) , alcohol intake treatment slow-release L-cysteine placebo . Patients biopsy-confirmed atrophic gastritis , low serum pepsinogen high gastrin-17 study . On separate day , patient randomly assign receive 200 mg slow-release L-cysteine placebo , intragastric instillation 15 % ( 0.3 g/kg ) ethanol . After intake , gastric concentration acetaldehyde , ethanol , L-cysteine MTCA analyse 4 hour . Expected result show mitigated exposure gastric mucosa acetaldehyde .</brief_summary>
	<brief_title>L-cysteine Prevents Stomach Exposure Carcinogenic Acetaldehyde</brief_title>
	<detailed_description>Gastric infection Helicobacter pylorus induces chronic active gastritis year develop atrophic gastritis hypochlorhydric milieu risk factor gastric cancer . Microbes colonize acid-free stomach oxidize ethanol acetaldehyde , consider group 1 carcinogen . The aim study ass gastric production acetaldehyde inert condensation product , non-toxic 4-methyltiazolidine-2-carboxylic acid ( MTCA ) , alcohol intake treatment slow-release L-cysteine . Identical placebo tablet use comparison . Patients biopsy-confirmed atrophic gastritis , low serum pepsinogen high gastrin-17 study case-control design . All subject control . On separate day , patient randomly assign receive 200 mg slow-release L-cysteine placebo , intragastric instillation 15 % ( 0.3 g/kg ) ethanol ( correspond two glass wine ) . After intake , gastric sample fluid period four hour do concentration acetaldehyde , ethanol , L-cysteine MTCA analyse . L-cysteine expect decrease gastric acetaldehyde concentration increase MTCA level . Gastric L-cysteine MTCA concentration expect maintained study period . With placebo , acetaldehyde expect elevate along ethanol concentration . Based assumption slow-release L-cysteine bind acetaldehyde form inactive MTCA , remain gastric juice result reduced local exposure gastric mucosa carcinogenic acetaldehyde .</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<mesh_term>Gastritis , Atrophic</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Helicobacterassociated chronic gastritis Hypochlorhydria Hypergastrinemia Hypopepsinogenemia Active peptic ulcer disease Other inflammatory gastrointestinal disease Gastrointestinal bleeding Gastrointestinal surgery Neurological disease Alcohol abuse Mental disorder Not able sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>atrohpic gastritis</keyword>
	<keyword>acetaldehyde</keyword>
	<keyword>ethanol</keyword>
	<keyword>L-cysteine</keyword>
</DOC>